Have had a read - will re-read later - frankly, not a bad result. PhII trials are learning trials and they may choose to tweak some things, but overall a pretty solid result. I think, if I've read it correctly, where things got a bit "weird' was the USA delivered an unexpected result from the "control group" which may have muddied the waters a little, but that's not a normal, so statistically I wouldn't take it to the bank. Others more medically minded will clarify, but certainly no major negative there.
Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3, page-141
-
- There are more pages in this discussion • 262 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.3¢ |
Change
-0.018(4.61%) |
Mkt cap ! $660.6M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 37.5¢ | 35.0¢ | $2.377M | 6.543M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 686812 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 106820 | 10 |
View Market Depth
| Last trade - 12.59pm 15/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |